US Blocks Funding for Risky Virus Research Abroad
The U.S. government has halted federal funding for gain-of-function research conducted in China, Iran, and other countries. This type of research involves altering viruses to make them more infectious or deadly. The decision aims to prevent potential pandemics and protect national security. Critics worry that such research could accidentally unleash dangerous pathogens.
Washington D.C. - The United States government has officially blocked federal funding for gain-of-function research taking place in China, Iran, and other nations, including within the U.S. This decision, formalized through an executive order, restricts taxpayer dollars from supporting studies that manipulate viruses to enhance their transmissibility or virulence. Proponents argue this type of research is crucial for understanding and preparing for potential pandemics. However, opponents contend that the risks associated with accidentally releasing a modified virus far outweigh the potential benefits. Concerns have been raised about biosafety and biosecurity protocols in foreign labs, making the transfer of U.S. funding a potentially dangerous proposition. The new policy is expected to face scrutiny from the scientific community, with debates likely to continue over the balance between pandemic preparedness and potential risks.